Login Register Cart 0
Current Pharmaceutical Design

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Potential Diagnostic Application of Artificial Intelligence in Breast Cancer

Author(s): Matineh Behzadi, Anahita Azinfar, Hawraa Ibrahim Alshakarchi, Yeganeh Khazaei, Ibrahim Saeed Gataa, Gordon A. Ferns, Hamid Naderi, Amir Avan*, Hamid Fiuji and Masoud Pezeshki Rad

Volume 31, Issue 29, 2025

Published on: 08 April, 2025

Page: [2305 - 2314] Pages: 10

DOI: 10.2174/0113816128369168250311172823

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Breast cancer poses a significant global health challenge, necessitating improved diagnostic and treatment strategies. This review explores the role of artificial intelligence (AI) in enhancing breast cancer pathology, emphasizing risk assessment, early detection, and analysis of histopathological and mammographic data. AI platforms show promise in predicting breast cancer risks and identifying tumors up to three years before clinical diagnosis. Deep learning techniques, particularly convolutional neural networks (CNNs), effectively classify cancer subtypes and grade tumor risk, achieving accuracy comparable to expert radiologists. Despite these advancements, challenges, such as the need for high-quality datasets and integration into clinical workflows, persist. Continued research on AI technologies is essential for advancing breast cancer detection and improving patient outcomes.

Keywords: Breast cancer, artificial intelligence, histopathological data, mammographic data, clinical diagnosis, convolutional neural networks.

Next »
[1]
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin 2022; 72(1): 7-33.
[http://dx.doi.org/10.3322/caac.21708] [PMID: 35020204]
[2]
Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 2018; 5(2): 77-106.
[http://dx.doi.org/10.1016/j.gendis.2018.05.001] [PMID: 30258937]
[3]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[4]
Faramarzi F, Zafari P, Alimohammadi M, Moonesi M, Rafiei A, Bekeschus S. Cold physical plasma in cancer therapy: Mechanisms, signaling, and immunity. Oxid Med Cell Longev 2021; 2021(1): 9916796.
[http://dx.doi.org/10.1155/2021/9916796] [PMID: 35284036]
[5]
Quinn C, Maguire A, Rakha E. Pitfalls in breast pathology. Histopathology 2023; 82(1): 140-61.
[http://dx.doi.org/10.1111/his.14799] [PMID: 36482276]
[6]
Bejnordi EB, Veta M, Johannes van Diest P, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 2017; 318(22): 2199-210.
[http://dx.doi.org/10.1001/jama.2017.14585] [PMID: 29234806]
[7]
Shafi S, Parwani AV. Artificial intelligence in diagnostic pathology. Diagn Pathol 2023; 18(1): 109.
[http://dx.doi.org/10.1186/s13000-023-01375-z] [PMID: 37784122]
[8]
Rakha EA, Reis-Filho JS, Ellis IO. Combinatorial biomarker expression in breast cancer. Breast Cancer Res Treat 2010; 120(2): 293-308.
[http://dx.doi.org/10.1007/s10549-010-0746-x] [PMID: 20107892]
[9]
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991; 19(5): 403-10.
[http://dx.doi.org/10.1111/j.1365-2559.1991.tb00229.x] [PMID: 1757079]
[10]
Keelan S, Flanagan M, Hill ADK. Evolving trends in surgical management of breast cancer: An analysis of 30 years of practice changing papers. Front Oncol 2021; 11: 622621.
[http://dx.doi.org/10.3389/fonc.2021.622621] [PMID: 34422626]
[11]
Wolff AC, Hammond MEH, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline focused update. Arch Pathol Lab Med 2018; 142(11): 1364-82.
[http://dx.doi.org/10.5858/arpa.2018-0902-SA] [PMID: 29846104]
[12]
Hammond MEH, Hayes DF, Dowsett M, et al. American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 2010; 134(7): e48-72.
[http://dx.doi.org/10.5858/134.7.e48] [PMID: 20586616]
[13]
Bockstal VMR, François A, Altinay S, et al. Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: The IVITA study. Mod Pathol 2021; 34(12): 2130-40.
[http://dx.doi.org/10.1038/s41379-021-00865-z] [PMID: 34218258]
[14]
Allison KH, Hammond MEH, Dowsett M, et al. Estrogen and progesterone receptor testing in breast cancer: Asco/cap guideline update. J Clin Oncol 2020; 38(12): 1346-66.
[http://dx.doi.org/10.1200/JCO.19.02309] [PMID: 31928404]
[15]
Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 2009; 133(10): 1515-38.
[http://dx.doi.org/10.5858/133.10.1515] [PMID: 19792042]
[16]
Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11(2): 155-68.
[PMID: 9504686]
[17]
Baxi V, Edwards R, Montalto M, Saha S. Digital pathology and artificial intelligence in translational medicine and clinical practice. Mod Pathol 2022; 35(1): 23-32.
[http://dx.doi.org/10.1038/s41379-021-00919-2] [PMID: 34611303]
[18]
Larsen M, Olstad CF, Koch HW, et al. AI risk score on screening mammograms preceding breast cancer diagnosis. Radiology 2023; 309(1): e230989.
[http://dx.doi.org/10.1148/radiol.230989] [PMID: 37847135]
[19]
Balasubramanian AA, Al-Heejawi SMA, Singh A, et al. Ensemble deep learning-based image classification for breast cancer subtype and invasiveness diagnosis from whole slide image histopathology. Cancers 2024; 16(12): 2222.
[http://dx.doi.org/10.3390/cancers16122222] [PMID: 38927927]
[20]
Sechopoulos I, Teuwen J, Mann R. Artificial intelligence for breast cancer detection in mammography and digital breast tomosynthesis: State of the art. Semin Cancer Biol 2021; 72: 214-25.
[http://dx.doi.org/10.1016/j.semcancer.2020.06.002] [PMID: 32531273]
[21]
Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005; 353(17): 1773-83.
[http://dx.doi.org/10.1056/NEJMoa052911] [PMID: 16169887]
[22]
Shah SM, Khan RA, Arif S, Sajid U. Artificial intelligence for breast cancer analysis: Trends & directions. Comput Biol Med 2022; 142: 105221.
[http://dx.doi.org/10.1016/j.compbiomed.2022.105221] [PMID: 35016100]
[23]
Saba T. Recent advancement in cancer detection using machine learning: Systematic survey of decades, comparisons and challenges. J Infect Public Health 2020; 13(9): 1274-89.
[http://dx.doi.org/10.1016/j.jiph.2020.06.033] [PMID: 32758393]
[24]
Yoon JH, Kim EK. Deep learning-based artificial intelligence for mammography. Korean J Radiol 2021; 22(8): 1225-39.
[http://dx.doi.org/10.3348/kjr.2020.1210] [PMID: 33987993]
[25]
Sandbank J, Bataillon G, Nudelman A, et al. Validation and real- world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies. NPJ Breast Cancer 2022; 8(1): 129.
[http://dx.doi.org/10.1038/s41523-022-00496-w] [PMID: 36473870]
[26]
Liu Y, Han D, Parwani AV, Li Z. Applications of artificial intelligence in breast pathology. Arch Pathol Lab Med 2023; 147(9): 1003-13.
[http://dx.doi.org/10.5858/arpa.2022-0457-RA] [PMID: 36800539]
[27]
Gandomkar Z, Brennan PC, Mello-Thoms C. MuDeRN: Multi-category classification of breast histopathological image using deep residual networks. Artif Intell Med 2018; 88: 14-24.
[http://dx.doi.org/10.1016/j.artmed.2018.04.005] [PMID: 29705552]
[28]
Ivanova M, Pescia C, Trapani D, et al. Early breast cancer risk assessment: Integrating histopathology with artificial intelligence. Cancers 2024; 16(11): 1981.
[http://dx.doi.org/10.3390/cancers16111981] [PMID: 38893102]
[29]
Sharma S, Mehra R. Conventional machine learning and deep learning approach for multi-classification of breast cancer histopathology images—a comparative insight. J Digit Imaging 2020; 33(3): 632-54.
[http://dx.doi.org/10.1007/s10278-019-00307-y] [PMID: 31900812]
[30]
Ibrahim A, Jahanifar M, Wahab N, et al. Artificial intelligence-based mitosis scoring in breast cancer: Clinical application. Mod Pathol 2024; 37(3): 100416.
[http://dx.doi.org/10.1016/j.modpat.2023.100416] [PMID: 38154653]
[31]
Ahn JS, Shin S, Yang SA, et al. Artificial intelligence in breast cancer diagnosis and personalized medicine. J Breast Cancer 2023; 26(5): 405-35.
[http://dx.doi.org/10.4048/jbc.2023.26.e45] [PMID: 37926067]
[32]
Sajjad U, Rezapour M, Su Z, Tozbikian GH, Gurcan MN, Niazi MKK. NRK-ABMIL: Subtle metastatic deposits detection for predicting lymph node metastasis in breast cancer whole-slide images. Cancers 2023; 15(13): 3428.
[http://dx.doi.org/10.3390/cancers15133428] [PMID: 37444538]
[33]
Holten-Rossing H, Talman MLM, Jylling AMB, Lænkholm AV, Kristensson M, Vainer B. Application of automated image analysis reduces the workload of manual screening of sentinel lymph node biopsies in breast cancer. Histopathology 2017; 71(6): 866-73.
[http://dx.doi.org/10.1111/his.13305] [PMID: 28677240]
[34]
Sajjadi E, Venetis K, Noale M, et al. Breast cancer during pregnancy as a special type of early-onset breast cancer: Analysis of the tumor immune microenvironment and risk profiles. Cells 2022; 11(15): 2286.
[http://dx.doi.org/10.3390/cells11152286] [PMID: 35892583]
[35]
Wang Z, Katsaros D, Wang J, et al. Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival. Sci Rep 2023; 13(1): 18962.
[http://dx.doi.org/10.1038/s41598-023-45932-4] [PMID: 37923775]
[36]
Sajjadi E, Venetis K, Scatena C, Fusco N. Biomarkers for precision immunotherapy in the metastatic setting: Hope or reality? Ecancermed sci 2020; 14: 1150.
[http://dx.doi.org/10.3332/ecancer.2020.1150] [PMID: 33574895]
[37]
Thagaard J, Broeckx G, Page DB, et al. Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the international immuno-oncology biomarker working group on breast cancer. J Pathol 2023; 260(5): 498-513.
[http://dx.doi.org/10.1002/path.6155] [PMID: 37608772]
[38]
Stewart MD, Vega MD, Arend RC, et al. Homologous recombination deficiency: Concepts, definitions, and assays. Oncologist 2022; 27(3): 167-74.
[http://dx.doi.org/10.1093/oncolo/oyab053] [PMID: 35274707]
[39]
Lazard T, Bataillon G, Naylor P, et al. Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images. Cell Rep Med 2022; 3(12): 100872.
[http://dx.doi.org/10.1016/j.xcrm.2022.100872] [PMID: 36516847]
[40]
Anaby D, Shavin D, Zimmerman-Moreno G, Nissan N, Friedman E, Sklair-Levy M. ‘Earlier than early’ detection of breast cancer in Israeli BRCA mutation carriers applying AI-based analysis to consecutive MRI scans. Cancers 2023; 15(12): 3120.
[http://dx.doi.org/10.3390/cancers15123120] [PMID: 37370730]
[41]
Loibl S, André F, Bachelot T, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2024; 35(2): 159-82.
[http://dx.doi.org/10.1016/j.annonc.2023.11.016] [PMID: 38101773]
[42]
Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: Benefits, risks, and strategies for success. NPJ Digit Med 2020; 3(1): 17.
[http://dx.doi.org/10.1038/s41746-020-0221-y] [PMID: 32047862]
[43]
Pai R, Karki S, Agarwal R, Sieber S, Barasch S. Optimal settings and clinical validation for automated Ki67 calculation in neuroendocrine tumors with open source informatics (QuPath). J Pathol Inform 2022; 13: 100141.
[http://dx.doi.org/10.1016/j.jpi.2022.100141] [PMID: 36268106]
[44]
Caldonazzi N, Rizzo PC, Eccher A, et al. Value of artificial intelligence in evaluating lymph node metastases. Cancers 2023; 15(9): 2491.
[http://dx.doi.org/10.3390/cancers15092491] [PMID: 37173958]
[45]
Janowczyk A, Zuo R, Gilmore H, Feldman M, Madabhushi A. HistoQC: An open-source quality control tool for digital pathology slides. JCO Clin Cancer Inform 2019; 3(3): 1-7.
[http://dx.doi.org/10.1200/CCI.18.00157] [PMID: 30990737]
[46]
Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A. Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology. Nat Rev Clin Oncol 2019; 16(11): 703-15.
[http://dx.doi.org/10.1038/s41571-019-0252-y] [PMID: 31399699]
[47]
Ragab DA, Sharkas M, Marshall S, Ren J. Breast cancer detection using deep convolutional neural networks and support vector machines. PeerJ 2019; 7: e6201.
[http://dx.doi.org/10.7717/peerj.6201] [PMID: 30713814]
[48]
Wang L. Mammography with deep learning for breast cancer detection. Front Oncol 2024; 14: 1281922.
[http://dx.doi.org/10.3389/fonc.2024.1281922] [PMID: 38410114]
[49]
Bhowmik A, Eskreis-Winkler S. Deep learning in breast imaging. BJR|Open 2022; 4(1): 20210060.
[http://dx.doi.org/10.1259/bjro.20210060] [PMID: 36105427]
[50]
Lehman CD, Yala A, Schuster T, et al. Mammographic breast density assessment using deep learning: Clinical implementation. Radiology 2019; 290(1): 52-8.
[http://dx.doi.org/10.1148/radiol.2018180694] [PMID: 30325282]
[51]
Yala A, Schuster T, Miles R, Barzilay R, Lehman C. A deep learning model to triage screening mammograms: A simulation study. Radiology 2019; 293(1): 38-46.
[http://dx.doi.org/10.1148/radiol.2019182908] [PMID: 31385754]
[52]
Becker AS, Marcon M, Ghafoor S, Wurnig MC, Frauenfelder T, Boss A. Deep learning in mammography. Invest Radiol 2017; 52(7): 434-40.
[http://dx.doi.org/10.1097/RLI.0000000000000358] [PMID: 28212138]
[53]
Subasi ID, Özçelik ŞB. Artificial intelligence in breast imaging: Opportunities, challenges, and legal-ethical considerations. Eurasian J Med 2023; 55(1): 114-9.
[PMID: 39128072]
[54]
Xavier D, Miyawaki I, Jorge CCA, et al. Artificial intelligence for triaging of breast cancer screening mammograms and workload reduction: A meta-analysis of a deep learning software. J Med Screen 2024; 31(3): 157-65.
[http://dx.doi.org/10.1177/09691413231219952] [PMID: 38115810]
[55]
Tizhoosh HR, Pantanowitz L. Artificial intelligence and digital pathology: Challenges and opportunities. J Pathol Inform 2018; 9(1): 38.
[http://dx.doi.org/10.4103/jpi.jpi_53_18] [PMID: 30607305]
[56]
Bi WL, Hosny A, Schabath MB, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin 2019; 69(2): 127-57.
[http://dx.doi.org/10.3322/caac.21552] [PMID: 30720861]
[57]
Ibrahim A, Gamble P, Jaroensri R, et al. Artificial intelligence in digital breast pathology: Techniques and applications. Breast 2020; 49: 267-73.
[http://dx.doi.org/10.1016/j.breast.2019.12.007] [PMID: 31935669]
[58]
Andrew A, Tizzard E. Large language models for improving cancer diagnosis and management in primary health care settings. J Med Surge Public Health 2024; 4: 100157.
[http://dx.doi.org/10.1016/j.glmedi.2024.100157]
[59]
AlSamhori JF, AlSamhori ARF, Duncan LA, et al. Artificial intelligence for breast cancer: Implications for diagnosis and management. J Med Surg Public Health 2024; 3: 100120.
[http://dx.doi.org/10.1016/j.glmedi.2024.100120]
[60]
Cui M, Zhang DY. Artificial intelligence and computational pathology. Lab Invest 2021; 101(4): 412-22.
[http://dx.doi.org/10.1038/s41374-020-00514-0] [PMID: 33454724]
[61]
Pagallo U, O’Sullivan S, Nevejans N, et al. The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations. Health Technol 2024; 14(1): 1-14.
[http://dx.doi.org/10.1007/s12553-023-00806-7] [PMID: 38229886]
[62]
Shimabukuro DW, Barton CW, Feldman MD, Mataraso SJ, Das R. Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: A randomised clinical trial. BMJ Open Respir Res 2017; 4(1): e000234.
[http://dx.doi.org/10.1136/bmjresp-2017-000234] [PMID: 29435343]
[63]
Uwimana A, Gnecco G, Riccaboni M. Artificial intelligence for breast cancer detection and its health technology assessment: A scoping review. Comput Biol Med 2025; 184: 109391.
[http://dx.doi.org/10.1016/j.compbiomed.2024.109391] [PMID: 39579663]
[64]
Hanna MG, Hanna MH. Current applications and challenges of artificial intelligence in pathology. Human Path Rep 2022; 27: 300596.
[http://dx.doi.org/10.1016/j.hpr.2022.300596]
[65]
Tilala HM, Chenchala KP, Choppadandi A, et al. Ethical considerations in the use of artificial intelligence and machine learning in health care: A comprehensive review. Cureus 2024; 16(6): e62443.
[http://dx.doi.org/10.7759/cureus.62443] [PMID: 39011215]
[66]
Khalid N, Qayyum A, Bilal M, Al-Fuqaha A, Qadir J. Privacy-preserving artificial intelligence in healthcare: Techniques and applications. Comput Biol Med 2023; 158: 106848.
[http://dx.doi.org/10.1016/j.compbiomed.2023.106848] [PMID: 37044052]
[67]
Jaime FJ, Muñoz A, Rodríguez-Gómez F, Jerez-Calero A. Strengthening privacy and data security in biomedical microelectromechanical systems by IoT communication security and protection in smart healthcare. Sensors 2023; 23(21): 8944.
[http://dx.doi.org/10.3390/s23218944]

Rights & Permissions Print Cite
Article Metrics
Pdf icon 32
Html icon 2
Find your institution